Log in or Sign up for Free to view tailored content for your specialty!
Geriatrics News
New AAD President Susan C. Taylor, MD, will focus on ‘taking care of dermatologists’
ORLANDO — Outgoing American Academy of Dermatology President Seemal R. Desai, MD, FAAD, passed the torch to Susan C. Taylor, MD, FAAD, who said she will continue pushing efforts to unify the organization during “a time of great disruption.”
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
The CMS finalized cuts to the 2025 physician fee schedule for the fifth year in a row, prompting an urgent call-to-action from the American Academy of Dermatology. HHS, through the CMS, announced the finalization of the 2025 Medicare Physician Fee Schedule.
Top news of July: Permanent makeup, FDA approvals, tattoos, more
Healio has compiled July’s most-read news in dermatology.
Log in or Sign up for Free to view tailored content for your specialty!
Top news of June: Cancer risk, leaf extract, fungal infections, more
Healio has compiled June’s most-read news in dermatology.
Top news of April: Product rankings, counterfit Botox, solar eclipse
Healio has compiled April’s most-read news in dermatology.
Actinic keratosis incidence rates remain high in older populations
Actinic keratosis remains a public health problem for older adults, occurring in approximately three of every 10 Medicare recipients, according to a research letter published in JAMA Dermatology.
Nomacopan well tolerated in bullous pemphigoid treatment
Nomacopan was well tolerated and beneficial in patients with bullous pemphigoid, according to phase 2a clinical trial results.
Researchers organize bullous pemphigoid by three main profiles
Researchers identified three different clusters of bullous pemphigoid, the most common autoimmune blistering disorder, according to a study published in the Journal of American Academy of Dermatology.
Findings shed light on humoral response in gliptin-associated bullous pemphigoid
The humoral response to BP180 and BP230 antigens is weakened in certain patients with gliptin-associated bullous pemphigoid, according to a study.
Bullous pemphigoid increases cardiovascular disease mortality risk
Patients with bullous pemphigoid experienced increases in cardiovascular mortality risk at 1, 3 and 5 years compared with matched controls, according to a study.
-
Headline News
Cancer surgeon runs the globe to raise testicular cancer awareness
March 21, 20258 min read -
Headline News
FDA launches online database for chemical containment levels in food
March 20, 20251 min read -
Headline News
‘Early events’ can increase a person’s risk for long COVID
March 20, 20253 min read
-
Headline News
Cancer surgeon runs the globe to raise testicular cancer awareness
March 21, 20258 min read -
Headline News
FDA launches online database for chemical containment levels in food
March 20, 20251 min read -
Headline News
‘Early events’ can increase a person’s risk for long COVID
March 20, 20253 min read